Crossref
The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer
Cancer Letters · 2026-11 · 218930
DOI: 10.1016/j.canlet.2026.218930 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2026-11. Verfasst von Yutong Zhao und 8 weiteren Autor:innen. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zhao, Y., Wang, Y., Zhang, X., Chen, L., Qin, C., Zhao, B., Li, Z., Li, T., & Wang, W. (2026). The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer. Cancer Letters, 218930. https://doi.org/10.1016/j.canlet.2026.218930
Vancouver
Zhao Y, Wang Y, Zhang X, Chen L, Qin C, Zhao B, et al. The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer. Cancer Letters. 2026:218930. doi:10.1016/j.canlet.2026.218930
BibTeX
@article{Zhao2026,
author = {Zhao, Yutong and Wang, Yuanyang and Zhang, Xiangyu and Chen, Lin and Qin, Cheng and Zhao, Bangbo and Li, Zeru and Li, Tianyu and Wang, Weibin},
title = {The EGR1-WDR5/SET1A-SERPINB1 epigenetic axis promotes gemcitabine resistance by suppressing pyroptosis in pancreatic cancer},
journal = {Cancer Letters},
year = {2026},
pages = {218930},
doi = {10.1016/j.canlet.2026.218930}
}
EUVIMED